BiPAP vs. CPAP: Which One Is Right for You?

Positive airway pressure therapy is the most effective treatment for obstructive sleep apnea, but "PAP therapy" encompasses several distinct device types that work in meaningfully different ways. For the vast majority of patients with straightforward OSA, continuous positive airway pressure — CPAP — is adequate, evidence-backed, and the appropriate first-line choice. For a smaller but important group of patients, however, CPAP either fails to control their breathing disorder or creates pressure-related discomfort that prevents consistent use. That is where bilevel positive airway pressure — BiPAP — enters the picture. "The single biggest mistake clinicians make is assuming that PAP therapy means CPAP and leaving it at that," says Dr. Rachel Simone, a sleep medicine researcher at Stanford. "BiPAP and APAP exist precisely because one pressure profile does not fit every patient."

Understanding the distinction between these devices requires understanding what they actually deliver — and why the difference matters physiologically.

How CPAP works — and where it falls short

CPAP delivers a constant, unvarying stream of pressurized air through a mask sealed against the face. That pressure acts as a pneumatic splint, holding the upper airway open throughout the sleep cycle regardless of whether the patient is inhaling or exhaling. The single-pressure approach is elegantly simple and therapeutically effective: in large randomized trials, consistent CPAP use eliminates most apneic events, restores oxygen saturation, and resolves the cascade of physiological consequences that untreated OSA produces.

The problem is that breathing against a constant pressure feels unnatural. During normal breathing, exhalation is a passive, effortless process — the respiratory muscles relax and the chest wall recoils. With CPAP, patients must actively exhale against the incoming air pressure to expel carbon dioxide. At lower prescribed pressures (6–10 cm H₂O), most people adapt to this sensation within a few weeks. At higher pressures — which are necessary to control severe OSA or obesity-related airway obstruction — the sensation of "breathing against the machine" becomes pronounced enough that some patients cannot tolerate the device at all.

How BiPAP differs: two pressures, one device

BiPAP solves the exhalation problem by delivering two distinct pressure levels. The inspiratory positive airway pressure (IPAP) is set higher — often between 10 and 25 cm H₂O — to provide the pneumatic support needed to keep the airway open during inhalation. The expiratory positive airway pressure (EPAP) is set lower — typically 4 to 8 cm H₂O — to reduce the work of breathing during exhalation while still maintaining enough back-pressure to prevent airway collapse. The device detects the transition between inhalation and exhalation and switches pressures accordingly, usually within milliseconds.

The practical result is that exhalation feels dramatically more natural with BiPAP than with CPAP at equivalent therapeutic pressures. Patients who have failed CPAP specifically because of exhalation discomfort frequently find BiPAP tolerable when CPAP was not. "The pressure difference between IPAP and EPAP — what we call the pressure support — is the key variable," says Dr. James Whitfield, a sleep medicine specialist at Cleveland Clinic. "For patients who need high therapeutic pressures, giving them even 4 to 6 cm H₂O of pressure support on exhalation can mean the difference between using the device and abandoning it after two weeks."

Who should consider BiPAP?

BiPAP is not simply a more comfortable version of CPAP — it has specific clinical indications that go beyond patient preference. The clearest indications include:

Patients who struggle to exhale against CPAP

When a patient requires a CPAP pressure above approximately 15 cm H₂O and reports significant exhalation difficulty, BiPAP is a reasonable next step. The pressure-support differential effectively lowers the work of breathing without compromising airway patency.

Complex and treatment-emergent central sleep apnea

Some patients who begin CPAP therapy develop central apneas — breathing pauses caused not by airway obstruction but by the brain failing to send the respiratory drive signal — in a pattern called treatment-emergent central sleep apnea or complex sleep apnea syndrome. Standard CPAP cannot address central events. BiPAP in its spontaneous-timed (BiPAP-ST) mode, or adaptive servo-ventilation (ASV) in more severe cases, provides a backup respiratory rate that prevents central apnea events.

Primary central sleep apnea

In patients whose sleep apnea is centrally mediated from the outset — not obstructive — BiPAP-ST provides ventilatory support that CPAP cannot offer.

COPD with nocturnal hypoventilation

Patients with chronic obstructive pulmonary disease who hypoventilate during sleep — retaining carbon dioxide because their respiratory muscles fatigue — need pressure support, not just airway splinting. BiPAP's ability to augment tidal volume during inhalation addresses the hypoventilation that CPAP cannot correct.

Obesity hypoventilation syndrome

Obesity hypoventilation syndrome (OHS), characterized by a BMI typically above 40, daytime hypercapnia, and sleep-disordered breathing, frequently requires BiPAP rather than CPAP. The combination of a very high therapeutic pressure needed to keep a heavily loaded airway patent and the additional component of nocturnal hypoventilation makes BiPAP-ST the preferred device in most OHS guidelines.

CPAP failure due to pressure intolerance

Patients who have made a genuine effort to comply with CPAP — at least 90 days of consistent use is the standard insurance threshold — but who remain non-adherent specifically because of pressure-related discomfort are appropriate candidates for a BiPAP trial.

The middle ground: APAP

Between fixed CPAP and BiPAP lies auto-titrating positive airway pressure, or APAP. Unlike fixed CPAP, APAP continuously monitors breathing and adjusts the delivered pressure within a pre-set range — increasing pressure when it detects apneas, hypopneas, or flow limitation, and reducing pressure during periods of stable breathing. This allows patients to spend most of the night at lower, more comfortable pressures while the device escalates only when needed.

For patients whose discomfort with CPAP stems from uniformly high pressure rather than exhalation difficulty specifically, APAP often provides adequate relief without the added cost of BiPAP. Patients whose AHI is controlled at moderate pressures but who experience discomfort during the fraction of the night when high pressure is needed are good APAP candidates. Those with genuine exhalation difficulty or hypoventilation — the clearer BiPAP indications — are unlikely to find APAP sufficient.

Cost and insurance considerations

The price difference between device types is substantial. A standard fixed CPAP typically costs $400–$800 at retail, while APAP devices range from $600–$1,200. BiPAP devices start at approximately $1,000 for basic bilevel units and can exceed $3,500 for BiPAP-ST or ASV models with advanced features. Most major insurance plans, including Medicare, cover CPAP and BiPAP when medical necessity criteria are met — which generally means a documented AHI above 15 events per hour (or above 5 with symptoms) from a sleep study, combined with a provider's order.

For BiPAP specifically, many insurers require documented CPAP failure — typically defined as inadequate therapeutic response or documented intolerance after a 90-day CPAP trial — before approving coverage. Working with your prescribing physician to document the clinical rationale clearly is essential to avoiding out-of-pocket costs.

How to talk to your doctor about switching

If you are currently on CPAP and struggling, the most productive approach is to bring your device's compliance data — most modern CPAP machines store nightly AHI, leak rate, and usage hours on a data card or via cloud — to your follow-up appointment. Describe specifically whether the problem is exhalation difficulty, mask leak, pressure-related aerophagia, or persistent sleepiness despite seemingly adequate use. That clinical specificity guides whether a switch to APAP, BiPAP, or a mask change is the right next step. A vague complaint that the machine is "uncomfortable" is harder to act on than "I cannot exhale comfortably when the pressure goes above 14."

Frequently Asked Questions

Is BiPAP better than CPAP for everyone?

No. For most patients with uncomplicated obstructive sleep apnea, CPAP is equally effective, far less expensive, and simpler to use. BiPAP's advantages — primarily the dual-pressure profile that eases exhalation and the ability to provide ventilatory support — are most relevant for patients who cannot tolerate CPAP at the required pressure, those with central or complex sleep apnea, and those with comorbid conditions like obesity hypoventilation syndrome or COPD with hypoventilation.

What is the difference between BiPAP and CPAP in simple terms?

CPAP blows air at one fixed pressure throughout your entire breathing cycle — the same pressure whether you are inhaling or exhaling. BiPAP delivers a higher pressure when you breathe in (IPAP) and a lower pressure when you breathe out (EPAP). That lower exhalation pressure makes it significantly easier to breathe out against the device, which is why patients who struggle with CPAP exhalation often do much better on BiPAP.

Can I switch from CPAP to BiPAP on my own?

No — BiPAP requires a new prescription and a new device titrated by a sleep medicine specialist. The IPAP and EPAP settings must be calibrated to your specific airway pressure requirements, either during an in-lab titration study or through a closely monitored auto-titrating BiPAP trial. Using an incorrectly set BiPAP could leave your apneas untreated or, in cases of complex sleep apnea, could worsen central events.

Does insurance cover BiPAP?

Most insurance plans including Medicare will cover BiPAP when medical necessity is documented. This typically requires a qualifying sleep study result (AHI ≥15 or ≥5 with symptoms) and — for patients transitioning from CPAP — evidence of CPAP failure after a trial of at least 90 days. Your sleep medicine provider's office can work with your insurer to establish prior authorization and document the clinical rationale.

What is APAP and how is it different from BiPAP?

APAP (auto-titrating PAP) is a CPAP variant that automatically adjusts its single delivered pressure within a prescribed range based on detected breathing events — it increases pressure when it senses apneas or flow limitation and decreases it during stable breathing. Unlike BiPAP, APAP still delivers the same pressure during both inhalation and exhalation at any given moment. It helps patients who find fixed CPAP uncomfortable because of fluctuating pressure needs but does not solve the exhalation difficulty that BiPAP specifically addresses.